MIP Discovery
MIP Discovery is a developer of non-biological affinity reagents, nanoMIPs, for diagnostics and healthcare applications. nanoMIP technology enables the rapid development of polymer-based affinity reagents targeted to small molecules, proteins and viruses, amongst other targets.
Latest Content
Industry Insight
Developing Synthetic Affinity Reagents for Improved Diagnostics
To learn more about MIPS and why they are particularly suited for use in in vitro diagnostic assays, we spoke to Dr. Francesco Canfarotta, head of chemistry at MIP Discovery.
Product News
MIP Discovery Announces Drugs of Abuse Reagent Launch
MIP Discovery has announced the launch of its first drugs of abuse products which are able to recognize norfentanyl, the main urinary metabolite of fentanyl.
Product News
MIP Discovery Secures Significant Funding To Support Development of Global Rapid Response Diagnostics
MIP Discovery has announced it has secured a significant grant of funds from the Bill & Melinda Gates Foundation.
Advertisement
